Partnership Opportunities
Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.
Potential partnerships are available in these areas:
Therapeutics
- ADHD
- Allergy and Asthma – Mast Cells
- Asthma
- Asthma and Lung Inflammation
- Autoimmunity and Cancer
- Autoimmunity and Primary Immunodeficiency
- Bone Disorders and Malformations
- Brain Malformations
- Cancer – Cadherin-Mediated Interventions
- Cancer – Immunotherapy
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Solid Tumors
- Cancer – Solid Tumors
- Cancer – T cell conditioning
- Cancer – Target Validation
- Cerebellar Development
- Chronic Pain
- Concussion
- Congenital Disorders of Glycosylation
- Craniofacial Malformations – Clinical Data
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Group B Streptococcus
- Heart Arrhythmia
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemoglobinopathies
- Hemophilia – Immunomodulation Therapy
- Hemophilia – Intraosseous Lentiviral Therapy
- HIV Microbiomes
- HIV – CAR-T therapies
- HIV – Viral Reservoirs
- HIV – Transmission and Progression
- Hypoplastic Left Heart Syndrome
- Immunological Disorders
- Infantile Hemangiomas and Other Vascular Malformations
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Influenza – Vaccines
- Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM) – Microbiome
- Kawasaki Disease
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Lymphatic Malformations
- Lysosomal Storage Diseases – Newborn Screening
- Malaria – Dormant Liver Form
- Malaria – Host-Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Mitochondrial Diseases – Mouse Model and Patient Cell Lines
- Motor Impairments and Paralysis
- Obesity
- Pain
- Parasitic Diseases
- Peroxisomal Disorders
- Retinal Disorders
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Phosphosignaling Pathways
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Diagnostics
- Autism – Characterizing Protein Interactions
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Concussion
- Congenital Disorders – Mosaic Mutations
- Healthcare Associated Infections
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Immunoreactivity and Tolerance
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Immune Dysregulation Syndromes
- Infantile Hemangiomas and Other Vascular Malformations
- Kawasaki Disease
- Lupus – B-Cell Targets
- Metabolic Disorders – Newborn Screening
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Tuberculosis and Antimicrobial-Resistance
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Medical Devices
- Activity Trackers and Apps
- Craniofacial Malformations – Clinical Data
- Epilepsy – Medical Device Interventions
- Heart Arrhythmia
- Hemophilia – Gene Therapy
- Hypoplastic Left Heart Syndrome
- Motor Impairments and Paralysis
- Sleep Apnea
Vaccines
- Group B Streptococcus
- HIV Tissue Reservoirs
- HIV – Transmission and Progression
- Infectious Diseases – Immune Development
- Influenza – Vaccines
- Malaria – Dormant Liver Form
- Malaria – Human Immune Response
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Tuberculosis
Research Tools and Understanding Disease Pathways
- Addiction – Characterizing Pathways
- Allergy and Asthma – Mast Cells
- Anesthesia Risks
- Autism – Characterizing Protein Interactions
- Autoimmunity and Cancer
- Autoimmunity and Primary Immunodeficiency
- Asthma
- Asthma and Lung Inflammation
- Bone Disorders and Malformations
- Brain Overgrowth Diseases
- Brain Malformations
- Breathing Dysregulation
- Cancer – Cadherin-Mediated Interventions
- Cancer – Immunotherapy
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Solid Tumors
- Cancer – Solid Tumors
- Cancer – Target Validation
- Cerebellar Development
- Congenital Disorders of Glycosylation
- Congenital Disorders – Mosaic Mutations
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Food Insecurity and Chronic Disease Management
- Healthcare Associated Infections
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemoglobinopathies
- HIV Microbiomes
- HIV Tissue Reservoirs
- HIV – Transmission and Progression
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Hypoplastic Left Heart Syndrome
- Immunological Disorders
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Influenza – Vaccines
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Lysosomal Storage Diseases – Newborn Screening
- Malaria – Dormant Liver Form
- Malaria – Host Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Metabolic Disorders – Newborn Screening
- Mitochondrial Disease
- Mitochondrial Diseases – Mouse Model and Patient Cell Lines
- MRSA Infections
- Obesity
- Organ Development
- Parasitic Diseases
- Peroxisomal Disorders
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Stroke
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Antimicrobial-Resistance
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Educational Products and Digital Health
- Activity and Fitness
- Activity Trackers and Apps
- ADHD
- Adolescent-Focused Digital Health Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Pain
- Sleep Science – Researching Child, Adolescent and Family Sleep
Learn More
To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners. please contact:
Dr. Elizabeth Aylward
Director, Office of Science–Industry Partnerships
Email
206-844-1065
